CDC
WASHINGTON - CDC has confirmed the influenza neuraminidase N1 subtype of the U.S. case of human avian influenza A(H5) reported last week by genetic sequencing. Genetic characterization is ongoing and final data will be made publicly available in GenBankexternal icon as soon as available.
Background. A person has tested positive for avian influenza A(H5) virus (H5 bird flu) in the U.S., as reported by Colorado and confirmed by CDC. This case occurred in a person who had direct exposure to poultry and was involved in the culling (depopulating) of poultry with presumptive H5N1 bird flu. The patient reported fatigue for a few days as their only symptom and has since recovered. The patient is being isolated and treated with the influenza antiviral drug oseltamivir.
Click here to learn more.
Source: CDC.gov
Latest from Pest Control Technology
- Envu Announces Launch of New Rewards Program
- Regulations, Science and Strategy Take Center Stage at Purdue Conference
- Selling Pest Control in the 21st Century
- Purdue Pest Management Conference Marks 90 Years
- Rentokil Initial Appoints Mike Duffy as CEO
- Harry Bryan Named VP of Business Development for Nisus Corporation
- Douglas Products Announces Planned CEO Transition
- Industry Veteran Richard Cruz Joins VM Products
